Answers are grounded in this paper and cite their sources.
In vitro immunological study reveals cross-reactive tropomyosin epitopes between shrimp and edible crickets in allergic sera, highlighting risk assessment targets for novel foods.
Tropomyosin is a pan-allergen in crustaceans known to cross-react with homologous proteins from edible insects. However, epitope-level cross-reactivity in edible insects remains poorly defined. This study aimed to identify IgE-binding epitopes of tropomyosin and to evaluate their cross-reactivity between shrimp and the edible two-spotted cricket. Here, sera from shrimp-allergic patients were screened for IgE-binding to proteins from Pacific white shrimp (Penaeus vannamei) and two-spotted cricket (Gryllus bimaculatus). Candidate tropomyosin epitopes from the two-spotted cricket were predicted. The cross-reactivity of tropomyosin was assessed using an inhibition dot blot assay, inhibition ELISA, and LAD2 cell degranulation assay. Approximately 40% of shrimp-allergic patients showed IgE reactivity to crude proteins from shrimp and the two-spotted cricket. Four identified peptide epitopes induced β-hexosaminidase release from LAD2 cells. These findings provide insights into the molecular basis of tropomyosin cross-reactivity essential for the development of biomarker-based tools for allergen risk assessment in the food industry.
No takes yet. Share an insight, caveat, or question.
Kumsui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: